Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3495021, 12 pages
https://doi.org/10.1155/2017/3495021
Research Article

Effect of Wenxin Granules on Gap Junction and MiR-1 in Rats with Myocardial Infarction

1Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China
2National Engineering Research Center for R&D of TCM Multi-Ingredient Drugs, Beijing 100079, China
3Beijing University of Chinese Medicine Institute for Cardiovascular Disease, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China

Correspondence should be addressed to Limin Chai; moc.liamtoh@iahcnimil

Received 16 January 2017; Accepted 20 August 2017; Published 28 September 2017

Academic Editor: Bo Zuo

Copyright © 2017 Aiming Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. B. Oliveira, A. Avezum, and L. Roever, “Cardiovascular disease burden: evolving knowledge of risk factors in myocardial infarction and stroke through population-based research and perspectives in global prevention,” Frontiers in Cardiovascular Medicine, vol. 2, article 32, 4 pages, 2015. View at Publisher · View at Google Scholar
  2. H. Seo, S.-J. Yoon, J. Yoon et al., “Recent trends in economic burden of acute myocardial infarction in South Korea,” PLoS ONE, vol. 10, no. 2, Article ID e0117446, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. B. H. Rao, “Global burden of sudden cardiac death and insights from India,” Indian Heart Journal, vol. 66, no. 1, pp. S18–S23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. D. V. Baklanov, L. A. Kaltenbach, S. P. Marso et al., “The prevalence and outcomes of transradial percutaneous coronary intervention for st-segment elevation myocardial infarction: Analysis from the national cardiovascular data registry (2007 to 2011),” Journal of the American College of Cardiology, vol. 61, no. 4, pp. 420–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Jabbari, “Ventricular fibrillation and sudden cardiac death during myocardial infarction,” The Danish Medical Journal, vol. 63, no. 5, p. B5246, 2016. View at Google Scholar
  6. C.-Y. Li and Y.-G. Li, “Cardiac sympathetic nerve sprouting and susceptibility to ventricular arrhythmias after myocardial infarction,” Cardiology Research and Practice, vol. 2015, Article ID 698368, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Glinge, S. Sattler, R. Jabbari, and J. Tfelt-Hansen, “Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction,” Journal of Geriatric Cardiology, vol. 13, no. 9, pp. 789–797, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. D. S. Echt, P. R. Liebson, L. B. Mitchell et al., “Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial,” The New England Journal of Medicine, vol. 324, no. 12, pp. 781–788, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Park, S. Beckman-Harned, G. Cho, D. Kim, and H. Kim, “The current acceptance, accessibility and recognition of Chinese and ayurvedic medicine in the United States in the public, governmental, and industrial sectors,” Chinese Journal of Integrative Medicine, vol. 18, no. 6, pp. 405–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Wang and X. Xiong, “Current situation and perspectives of clinical study in integrative medicine in China,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 268542, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Li, M. Guo, H. Mao, Z. Gao, H. Xu, and D. Shi, “Qing-Xin-Jie-Yu Granules in addition to conventional treatment for patients with stable coronary artery disease (QUEST Trial): study protocol for a randomized controlled trial,” Trials, vol. 17, no. 1, article no. 451, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-J. Shang, H. Shi, Q. Zhou, W. Gao, and H.-X. Liu, “A study of prognosis, outcome, and changing tendency of hospitalized AMI patients in Beijing third-grade A-level traditional Chinese medicine hospitals from 1999 to 2008,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 837194, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-X. Liu, S.-R. Wang, Y. Lei, and J.-J. Shang, “Characteristics and advantages of traditional Chinese medicine in the treatment of acute myocardial infarction,” Journal of Traditional Chinese Medicine, vol. 31, no. 4, pp. 269–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Kalifa and U. M. R. Avula, “The Chinese herb extract Wenxin Keli: atrial selectivity from the Far East,” Heart Rhythm, vol. 9, no. 1, pp. 132-133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Chen, X. Xiong, C. Wang et al., “The effects of wenxin keli on left ventricular ejection fraction and brain natriuretic peptide in patients with heart failure: a meta-analysis of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 242589, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Wang, Y. Gu, T. Wang, and C. Huang, “Wenxin Keli attenuates ischemia-induced ventricular arrhythmias in rats: involvement of L-type calcium and transient outward potassium currents,” Molecular Medicine Reports, vol. 7, no. 2, pp. 519–524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Xing, Y. Gao, J. Chen et al., “Wenxin-Keli regulates the calcium/calmodulin-dependent protein kinase II signal transduction pathway and inhibits cardiac arrhythmia in rats with myocardial infarction,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 464508, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Wu, J. Zhai, D. Zhang et al., “Effect of wenxin granule on ventricular remodeling and myocardial apoptosis in rats with myocardial infarction,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 967986, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Burashnikov, A. Petroski, D. Hu, H. Barajas-Martinez, and C. Antzelevitch, “Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation,” Heart Rhythm, vol. 9, no. 1, pp. 125–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. F. S. Ng, J. M. Kalindjian, S. A. Cooper et al., “Enhancement of gap junction function during acute myocardial infarction modifies healing and reduces late ventricular arrhythmia susceptibility,” JACC: Clinical Electrophysiology, vol. 2, no. 5, pp. 574–582, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. G. G. Hesketh, M. H. Shah, V. L. Halperin et al., “Ultrastructure and regulation of lateralized connexin43 in the failing heart,” Circulation Research, vol. 106, no. 6, pp. 1153–1163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. K. Priya and M. Reddy, “Regional variation of gap junction conductance on reentrant arrhythmia,” Biomedical sciences instrumentation, vol. 51, pp. 281–288, 2015. View at Google Scholar
  24. P. M. Patel, A. Plotnikov, P. Kanagaratnam et al., “Altering ventricular activation remodels gap junction distribution in canine heart,” Journal of Cardiovascular Electrophysiology, vol. 12, no. 5, pp. 570–577, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-C. Hsieh, J.-C. Lin, C.-Y. Hung et al., “Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit hearts,” Heart Rhythm, vol. 13, no. 1, pp. 251–261, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Rutledge, F. S. Ng, M. S. Sulkin et al., “C-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction,” Journal of the American College of Cardiology, vol. 63, no. 9, pp. 928–934, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Bao, J. Jiang, T. Yanase, Y. Nishi, and J. R. Morgan, “Connexon-mediated cell adhesion drives microtissue self-assembly,” FASEB Journal, vol. 25, no. 1, pp. 255–264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. D. W. Laird, K. L. Puranam, and J.-P. Revel, “Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes,” Biochemical Journal, vol. 273, no. 1, pp. 67–72, 1991. View at Publisher · View at Google Scholar · View at Scopus
  29. L. S. Musil and D. A. Goodenough, “Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques,” Journal of Cell Biology, vol. 115, no. 5, pp. 1357–1374, 1991. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Pogoda, P. Kameritsch, M. A. Retamal, and J. L. Vega, “Regulation of gap junction channels and hemichannels by phosphorylation and redox changes: a revision,” BMC Cell Biology, vol. 17, supplement 1, pp. 137–150, 2016. View at Google Scholar
  31. M. Vinken, “Regulation of connexin signaling by the epigenetic machinery,” Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, vol. 1859, no. 2, pp. 262–268, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Guo, N. T. Ingolia, J. S. Weissman, and D. P. Bartel, “Mammalian microRNAs predominantly act to decrease target mRNA levels,” Nature, vol. 466, no. 7308, pp. 835–840, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Kozomara and S. Griffiths-Jones, “miRBase: annotating high confidence microRNAs using deep sequencing data,” Nucleic Acids Research, vol. 42, pp. D68–D73, 2013. View at Publisher · View at Google Scholar
  34. Y. Wei and A. Schober, “MicroRNA regulation of macrophages in human pathologies,” Cellular and Molecular Life Sciences, vol. 73, no. 18, pp. 3473–3495, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Sermersheim, K. H. Park, K. Gumpper et al., “MicroRNA regulation of autophagy in cardiovascular disease,” Frontiers in Bioscience, vol. 22, no. 1, pp. 48–65, 2017. View at Google Scholar
  36. M. W. Feinberg and K. J. Moore, “MicroRNA regulation of atherosclerosis,” Circulation Research, vol. 118, no. 4, pp. 703–720, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. G. H. Kim, “MicroRNA regulation of cardiac conduction and arrhythmias,” Translational Research, vol. 161, no. 5, pp. 381–392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Luo, H. Lin, Z. Pan et al., “Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart,” Journal of Biological Chemistry, vol. 283, no. 29, pp. 20045–20052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Zhao, J. F. Ransom, and A. Li, “Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2,” Cell, vol. 129, no. 2, pp. 303–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Wu, D. Wu, C. Wang, Z. Guo, B. Li, and Z. Zuo, “Hexabromocyclododecane exposure induces cardiac hypertrophy and arrhythmia by inhibiting miR-1 expression via up-regulation of the homeobox gene Nkx2.5,” Journal of Hazardous Materials, vol. 302, pp. 304–313, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. P. L. Hedley, A. L. Carlsen, K. M. Christiansen et al., “MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 74, no. 6, pp. 485–491, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Sygitowicz, M. Tomaniak, O. Błaszczyk, Ł. Kołtowski, K. J. Filipiak, and D. Sitkiewicz, “Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: preliminary results,” Archives of Cardiovascular Diseases, vol. 108, no. 12, pp. 634–642, 2015. View at Publisher · View at Google Scholar
  43. E. Boštjančič, N. Zidar, D. Štajer, and D. Glavač, “MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction,” Cardiology, vol. 115, no. 3, pp. 163–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Yang, H. Lin, and J. Xiao, “The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2,” Nature Medicine, vol. 13, no. 4, pp. 486–491, 2007. View at Publisher · View at Google Scholar
  45. A. C. Cone, G. Cavin, C. Ambrosi et al., “Protein kinase Cδ-mediated phosphorylation of connexin43 gap junction channels causes movement within gap junctions followed by vesicle internalization and protein degradation,” Journal of Biological Chemistry, vol. 289, no. 13, pp. 8781–8798, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. H.-L. Hsieh, C.-Y. Wu, and C.-M. Yang, “Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-δ-dependent ERK/Elk-1 pathway in astrocytes,” Glia, vol. 56, no. 6, pp. 619–632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Janknecht and A. Nordheim, “Elk-1 protein domains required for direct and SRF-assisted DNA-binding,” Nucleic Acids Research, vol. 20, no. 13, pp. 3317–3324, 1992. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Niu, A. Li, S. X. Zhang, and R. J. Schwartz, “Serum response factor micromanaging cardiogenesis,” Current Opinion in Cell Biology, vol. 19, no. 6, pp. 618–627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. K.-H. Tsai, N.-H. Lee, G.-Y. Chen et al., “Dung-shen (Codonopsis pilosula) attenuated the cardiac-impaired insulin-like growth factor II receptor pathway on myocardial cells,” Food Chemistry, vol. 138, no. 2-3, pp. 1856–1867, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. B.-R. Yang, K.-K. Cheung, X. Zhou et al., “Amelioration of acute myocardial infarction by saponins from flower buds of Panax notoginseng via pro-angiogenesis and anti-apoptosis,” Journal of Ethnopharmacology, vol. 181, pp. 50–58, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. S.-Y. Han, H.-X. Li, X. Ma et al., “Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 722–727, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Wang, Y. Ren, L. Xing et al., “Endothelium-dependent vasodilation effects of Panax notoginseng and its main components are mediated by nitric oxide and cyclooxygenase pathways,” Experimental and Therapeutic Medicine, vol. 12, no. 6, pp. 3998–4006, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Maiwulanjiang, J. Chen, G. Xin et al., “The volatile oil of Nardostachyos Radix et Rhizoma inhibits the oxidative stress-induced cell injury via reactive oxygen species scavenging and Akt activation in H9c2 cardiomyocyte,” Journal of Ethnopharmacology, vol. 153, no. 2, pp. 491–498, 2014. View at Publisher · View at Google Scholar · View at Scopus